Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Summary

Expanded access to Avelumab solution for infusion will be made available for adult patients with mMCC whose disease has progressed after receiving at least one prior chemotherapy.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications